|Quest Diagnostics Declares Quarterly Cash Dividend|
|SECAUCUS, N.J., Aug. 17, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on October 22, 2018 to shareholders of record of Quest Diagnostics common stock on October 5, 2018.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived fr... ||08/17/18|
|Quest Diagnostics Earns Gold Status in American Heart Association's Workplace Health Achievement Index|
|SECAUCUS, N.J., Aug. 16, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it achieved gold status in the American Heart Association's 2018 Workplace Health Achievement Index, ranking the company's workplace health program among the best in the nation.
The American Heart Association created the Index with its CEO Roundtable members, a leadership collaborative of more than ... ||08/16/18|
|New Quest Diagnostics Data Shows Lyme Disease Prevalence Increasing and is Now Present in New U.S. States|
|- Number of positive tests for Lyme disease increased significantly between 2016 and 2017.
- Historically concentrated in Pennsylvania and New England states, Lyme disease has been detected in each of the 50 United States and the District of Columbia.
- Outside of the northeastern U.S., California and Florida - states not historically associated with significant rates of Lyme disease - saw the largest absolute increases in positive Lyme disease test results.
- Notable increases also obs... ||07/30/18|
|Quest Diagnostics Reports Second Quarter 2018 Financial Results|
|-- Second quarter revenues of $1.92 billion, up 3.0% from 2017
-- Second quarter reported diluted EPS of $1.57, up 14.4% from 2017
-- Second quarter adjusted diluted EPS excluding amortization of $1.75, up 20.5% from 2017
-- Narrows outlook for full year 2018 revenues and diluted EPS. Revenues now expected to be between $7.70 billion and $7.74 billion. Reported diluted EPS now expected to be between $5.50 and $5.64 and adjusted diluted EPS excluding amortization expense now expected to ... ||07/24/18|